{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:55:28Z","timestamp":1789692928746,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.imbio.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T22:01:31Z","timestamp":1478210491000},"page":"544-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis"],"prefix":"10.1016","volume":"222","author":[{"given":"Yaron","family":"Ilan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Gingis-Velitski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Ben Ya\u2019aco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehudit","family":"Shabbat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidya","family":"Zolotarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einat","family":"Almon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoseph","family":"Shaaltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2016.11.001_bib0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2007.08009.x","article-title":"Development of Crohn disease in a patient on etanercept for psoriasis","volume":"157","author":"Ahmad","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0010","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.177.6.1575","article-title":"de Vries JE. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation","volume":"177","author":"Aversa","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2016.11.001_bib0015","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/00365520802699278","article-title":"Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies","volume":"44","author":"Bendtzen","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0020","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.4049\/jimmunol.1003372","article-title":"Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis","volume":"186","author":"Biton","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/eye.2011.320","article-title":"Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(\u2212) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study","volume":"26","author":"Calleja","year":"2012","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.imbio.2016.11.001_bib0030","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1053\/j.gastro.2011.09.015","article-title":"Gut-tropic T cells that express integrin alpha4beta7 and CCR9 are required for induction of oral immune tolerance in mice","volume":"141","author":"Cassani","year":"2011","journal-title":"Gastroenterology"},{"issue":"Suppl. 2","key":"10.1016\/j.imbio.2016.11.001_bib0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/S0007114512005223","article-title":"Gut immune system and oral tolerance","volume":"109","author":"Castro-Sanchez","year":"2013","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.imbio.2016.11.001_bib0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/gut.53.1.70","article-title":"Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease","volume":"53","author":"Di Sabatino","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.imbio.2016.11.001_bib0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ibd.22990","article-title":"Drug-induced inflammatory bowel disease and IBD-like conditions","volume":"19","author":"Dubeau","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.imbio.2016.11.001_bib0050","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1084\/jem.180.6.2173","article-title":"Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis","volume":"180","author":"Evans","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2016.11.001_bib0055","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.4049\/jimmunol.172.10.5908","article-title":"Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice","volume":"172","author":"Falcone","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1467-7652.2005.00154.x","article-title":"High-yield production of authentic human growth hormone using a plant virus-based expression system","volume":"3","author":"Gils","year":"2005","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.imbio.2016.11.001_bib0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.jidsymp.5650032","article-title":"Effects of etanercept are distinct from infliximab in modulating proinflammatory genes in activated human leukocytes","volume":"12","author":"Haider","year":"2007","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"10.1016\/j.imbio.2016.11.001_bib0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semarthrit.2008.06.004","article-title":"Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of action","volume":"39","author":"Haraoui","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.imbio.2016.11.001_bib0075","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2165\/00003495-200767170-00009","article-title":"Etanercept: a review of its use in the management of ankylosing spondylitis and psoriatic arthritis","volume":"67","author":"Hoy","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.imbio.2016.11.001_bib0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellimm.2012.09.001","article-title":"Anti-TNF-alpha therapy improves Treg and suppresses Teff in patients with rheumatoid arthritis","volume":"279","author":"Huang","year":"2012","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0085","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1073\/pnas.0908771107","article-title":"Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob\/ob mice","volume":"107","author":"Ilan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2016.11.001_bib0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10875-009-9323-7","article-title":"Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells","volume":"30","author":"Ilan","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.humimm.2009.06.018","article-title":"Oral tolerance: can we make it work","volume":"70","author":"Ilan","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0100","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1038\/cti.2015.47","article-title":"Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease","volume":"5","author":"Ilan","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0105","doi-asserted-by":"crossref","first-page":"G1102","DOI":"10.1152\/ajpgi.00095.2016","article-title":"Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance","volume":"310","author":"Ilan","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0110","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2337\/db06-1632","article-title":"Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody","volume":"56","author":"Ishikawa","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.imbio.2016.11.001_bib0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1756283X09351733","article-title":"Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease","volume":"3","author":"Israeli","year":"2010","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0120","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.171.3.941","article-title":"A novel addition to the T cell repertory: cell surface expression of tumor necrosis factor\/cachectin by activated normal human T cells","volume":"171","author":"Kinkhabwala","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2016.11.001_bib0125","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S1097-2765(03)00203-X","article-title":"JunD mediates survival signaling by the JNK signal transduction pathway","volume":"11","author":"Lamb","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.imbio.2016.11.001_bib0130","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI43792","article-title":"Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice","volume":"121","author":"Lerner","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2016.11.001_bib0135","doi-asserted-by":"crossref","first-page":"G917","DOI":"10.1152\/ajpgi.00105.2005","article-title":"Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes","volume":"289","author":"Margalit","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.crohns.2009.12.001","article-title":"A decade of infliximab: the Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease","volume":"4","author":"Miehsler","year":"2010","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.imbio.2016.11.001_bib0145","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2174\/138161209787846784","article-title":"The gut mucosa as a site for induction of regulatory T-cells","volume":"15","author":"Mizrahi","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.imbio.2016.11.001_bib0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/gut.2005.090464","article-title":"Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications","volume":"56","author":"Mudter","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.imbio.2016.11.001_bib0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2016.11.001_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2008.07.027","article-title":"New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity","volume":"274","author":"Ochi","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.imbio.2016.11.001_bib0165","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.3899\/jrheum.080219","article-title":"Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis","volume":"35","author":"Pang","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2010.06.002","article-title":"Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice","volume":"227","author":"Peron","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biopha.2006.06.022","article-title":"Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? a systematic meta-analysis of controlled clinical trials","volume":"61","author":"Rahimi","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.imbio.2016.11.001_bib0180","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.bcp.2010.02.008","article-title":"The intestinal antiinflammatory agent glycomacropeptide has immunomodulatory actions on rat splenocytes","volume":"79","author":"Requena","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.imbio.2016.11.001_bib0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/1153420-S0-000000000-00000","article-title":"Adverse effects of biological agents in the treatment of psoriasis","volume":"11","author":"Rongioletti","year":"2010","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0190","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imbio.2016.11.001_bib0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bpg.2010.01.002","article-title":"Adverse effects of biologics used for treating IBD","volume":"24","author":"Stallmach","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0200","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1167\/iovs.10-5916","article-title":"Induction of regulatory T cells by infliximab in Behcet's disease","volume":"52","author":"Sugita","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.imbio.2016.11.001_bib0205","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJM200402193500818","article-title":"Etanercept for crohn's disease","volume":"350","author":"Travers","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2016.11.001_bib0210","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imbio.2016.11.001_bib0215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(04)00166-7","article-title":"Tumor necrosis factor: an apoptosis JuNKie","volume":"116","author":"Varfolomeev","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2016.11.001_bib0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2011.01017.x","article-title":"Oral tolerance","volume":"241","author":"Weiner","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2016.11.001_bib0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/187153009789044347","article-title":"TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases","volume":"9","author":"Wiedmann","year":"2009","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.imbio.2016.11.001_bib0230","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.4049\/jimmunol.1000836","article-title":"Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant","volume":"185","author":"Wu","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0235","doi-asserted-by":"crossref","first-page":"425021","DOI":"10.1155\/2012\/425021","article-title":"Induction of immunological tolerance by oral anti-CD3","volume":"2012","author":"da Cunha","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.imbio.2016.11.001_bib0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.50.2.206","article-title":"Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease","volume":"50","author":"ten Hove","year":"2002","journal-title":"Gut"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298516304296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298516304296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:42:31Z","timestamp":1759250551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298516304296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0171298516304296"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2016.11.001","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}